CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer’s disease

被引：0
作者：
Alan J. Lerner
Steven E. Arnold
Erin Maxfield
Aaron Koenig
Maria E. Toth
Brooke Fortin
Natalia Mast
Bianca A. Trombetta
John Denker
Andrew A. Pieper
Curtis Tatsuoka
Sangeetha Raghupathy
Irina A. Pikuleva
机构：
[1] Brain Health and Memory Center,Department of Neurology
[2] Neurological Institute,Alzheimer’s Clinical and Translational Research Unit
[3] University Hospitals Cleveland Medical Center,Department of Ophthalmology and Visual Sciences
[4] Case Western Reserve University,Harrington Discovery Institute
[5] Massachusetts General Hospital,Department of Psychiatry
[6] Case Western Reserve University,Institute for Transformative Molecular Medicine, School of Medicine
[7] University Hospitals Cleveland Medical Center,Department of Population and Quantitative Health Sciences
[8] Case Western Reserve University,undefined
[9] Geriatric Psychiatry,undefined
[10] GRECC,undefined
[11] Louis Stokes Cleveland VA Medical Center,undefined
[12] Case Western Reserve University,undefined
[13] Case Western Reserve University,undefined
来源：
Alzheimer's Research & Therapy | / 14卷
关键词：
CYP46A1; Efavirenz; Alzheimer’s disease; 24-Hydroxycholesterol; Stable isotope labeling kinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 225 条
[31]  
Whitmer RA(2022)Low-dose anti-HIV drug efavirenz mitigates retinal vascular lesions in a mouse model of Alzheimer’s disease Front Pharmacol 13 902254-E383
[32]  
Reitz C(2008)Dose translation from animal to human studies revisited FASEB J 22 659-264
[33]  
Dietschy JM(2004)Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal J Lipid Res 45 1375-603
[34]  
Turley SD(2009)Central nervous system: cholesterol turnover, brain development and neurodegeneration Biol Chem 390 287-80
[35]  
Lutjohann D(1975)“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189-23
[36]  
Breuer O(1982)A new clinical scale for the staging of dementia Br J Psychiatry 140 566-2708
[37]  
Ahlborg G(2012)Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration J Clin Invest 122 3159-711
[38]  
Nennesmo I(1994)Measurement of fractional lipid synthesis using deuterated water (2H2O) and mass isotopomer analysis Am J Physiol 266 E372-91
[39]  
Siden A(2016)Cholesterol in mouse retina originates primarily from in situ de novo biosynthesis J Lipid Res 57 258-53
[40]  
Diczfalusy U(2011)Cholestenoic acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain Invest Ophthalmol Vis Sci 52 594-1476
12345678910